107 related articles for article (PubMed ID: 10879331)
1. Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase.
Davis JM; Richter SE; Biswas S; Rosenfeld WN; Parton L; Gewolb IH; Parad R; Carlo W; Couser RJ; Baumgart S; Atluru V; Salerno L; Kassem N
J Perinatol; 2000 Jun; 20(4):213-6. PubMed ID: 10879331
[TBL] [Abstract][Full Text] [Related]
2. Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome.
Davis JM; Rosenfeld WN; Richter SE; Parad MR; Gewolb IH; Spitzer AR; Carlo WA; Couser RJ; Price A; Flaster E; Kassem N; Edwards L; Tierney J; Horowitz S
Pediatrics; 1997 Jul; 100(1):24-30. PubMed ID: 9200356
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase.
Davis JM; Parad RB; Michele T; Allred E; Price A; Rosenfeld W;
Pediatrics; 2003 Mar; 111(3):469-76. PubMed ID: 12612223
[TBL] [Abstract][Full Text] [Related]
4. Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome.
Rosenfeld WN; Davis JM; Parton L; Richter SE; Price A; Flaster E; Kassem N
Pediatrics; 1996 Jun; 97(6 Pt 1):811-7. PubMed ID: 8657519
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of recombinant human copper zinc superoxide dismutase administered at birth to premature infants.
McBride JA; Parad RB; Davis JM; Zheng Z; Zupancic JA;
J Perinatol; 2009 May; 29(5):364-71. PubMed ID: 19225525
[TBL] [Abstract][Full Text] [Related]
6. Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase.
Parad RB; Allred EN; Rosenfeld WN; Davis JM
Neonatology; 2012; 102(2):139-44. PubMed ID: 22710821
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic interactions of exogenous lung surfactant and recombinant human Cu/Zn superoxide dismutase.
Davis JM; Rosenfeld WN; Koo HC; Gonenne A
Pediatr Res; 1994 Jan; 35(1):37-40. PubMed ID: 8134197
[TBL] [Abstract][Full Text] [Related]
8. Localization and activity of recombinant human CuZn superoxide dismutase after intratracheal administration.
Sahgal N; Davis JM; Robbins C; Horowitz S; Langenback EG; Perry RH; Colflesh D; Tierney J; Simon SR
Am J Physiol; 1996 Aug; 271(2 Pt 1):L230-5. PubMed ID: 8770061
[TBL] [Abstract][Full Text] [Related]
9. Increased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigs.
Kaipel M; Wagner A; Wassermann E; Vorauer-Uhl K; Kellner R; Redl H; Katinger H; Ullrich R
J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):281-90. PubMed ID: 18578594
[TBL] [Abstract][Full Text] [Related]
10. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
11. Improved pulmonary distribution of recombinant human Cu/Zn superoxide dismutase, using a modified ultrasonic nebulizer.
Langenback EG; Davis JM; Robbins C; Sahgal N; Perry RJ; Simon SR
Pediatr Pulmonol; 1999 Feb; 27(2):124-9. PubMed ID: 10088936
[TBL] [Abstract][Full Text] [Related]
12. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
[TBL] [Abstract][Full Text] [Related]
13. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide.
Mestan KK; Marks JD; Hecox K; Huo D; Schreiber MD
N Engl J Med; 2005 Jul; 353(1):23-32. PubMed ID: 16000353
[TBL] [Abstract][Full Text] [Related]
14. Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension.
Lakshminrusimha S; Russell JA; Wedgwood S; Gugino SF; Kazzaz JA; Davis JM; Steinhorn RH
Am J Respir Crit Care Med; 2006 Dec; 174(12):1370-7. PubMed ID: 17008638
[TBL] [Abstract][Full Text] [Related]
15. Inhaled nitric oxide for premature infants with severe respiratory failure.
Van Meurs KP; Wright LL; Ehrenkranz RA; Lemons JA; Ball MB; Poole WK; Perritt R; Higgins RD; Oh W; Hudak ML; Laptook AR; Shankaran S; Finer NN; Carlo WA; Kennedy KA; Fridriksson JH; Steinhorn RH; Sokol GM; Konduri GG; Aschner JL; Stoll BJ; D'Angio CT; Stevenson DK;
N Engl J Med; 2005 Jul; 353(1):13-22. PubMed ID: 16000352
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia.
Bassler D; Shinwell ES; Hallman M; Jarreau PH; Plavka R; Carnielli V; Meisner C; Engel C; Koch A; Kreutzer K; van den Anker JN; Schwab M; Halliday HL; Poets CF;
N Engl J Med; 2018 Jan; 378(2):148-157. PubMed ID: 29320647
[TBL] [Abstract][Full Text] [Related]
17. Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia.
Ahn SY; Chang YS; Kim JH; Sung SI; Park WS
J Pediatr; 2017 Jun; 185():49-54.e2. PubMed ID: 28341525
[TBL] [Abstract][Full Text] [Related]
18. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.
Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM
Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511
[TBL] [Abstract][Full Text] [Related]
19. Effects of exogenous surfactant and recombinant human copper-zinc superoxide dismutase on oxygen-dependent antimicrobial defenses.
Walti H; Nicolas-Robin A; Assous MV; Polla BS; Bachelet M; Davis JM
Biol Neonate; 2002 Aug; 82(2):96-102. PubMed ID: 12169831
[TBL] [Abstract][Full Text] [Related]
20. The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome.
Levine CR; Gewolb IH; Allen K; Welch RW; Melby JM; Pollack S; Shaffer T; Pilon AL; Davis JM
Pediatr Res; 2005 Jul; 58(1):15-21. PubMed ID: 15774846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
